Follow
Spyros N. Pavlou
Spyros N. Pavlou
Endocrine Clinics
Verified email at endocrine.gr - Homepage
Title
Cited by
Cited by
Year
Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe …
European Orgalutran® Study Group, G Borm, B Mannaerts
Human reproduction 15 (7), 1490-1498, 2000
4412000
A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing …
Ganirelix Dose-Finding Study Group
Human Reproduction 13 (11), 1998
3231998
Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells
D Minaretzis, M Jakubowski, JF Mortola, SN Pavlou
The Journal of Clinical Endocrinology & Metabolism 80 (2), 430-434, 1995
1901995
Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido
SN PAVLOU, KIM BREWER, MG FARLEY, J LINDNER, MC BASTIAS, ...
The Journal of Clinical Endocrinology & Metabolism 73 (6), 1360-1369, 1991
1441991
Granulosa cells as hormone targets: the role of biologically active follicle-stimulating hormone in reproduction
AJW Hsueh, TA Bicsak, XC Jia, KD Dahl, BCJM Fauser, AB Galway, ...
Proceedings of the 1988 Laurentian Hormone Conference, 209-277, 1989
1401989
Identification and characterization of three distinct atrial natriuretic factor receptors. Evidence for tissue-specific heterogeneity of receptor subtypes in vascular smooth …
KN Pandey, SN Pavlou, T Inagami
Journal of Biological Chemistry 263 (26), 13406-13413, 1988
1261988
Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation
A Djerassi, C Coutifaris, VA West, SL Asa, SC Kapoor, SN Pavlou, ...
The Journal of Clinical Endocrinology & Metabolism 80 (2), 591-594, 1995
1041995
The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist
KD Dah, SN Pavlou, WJ Kovacs, AJW Hsueh
The Journal of Clinical Endocrinology & Metabolism 63 (3), 792-794, 1986
1031986
Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function
TC KAMILARIS, CR DEBOLD, SN PAVLOU, DP ISLAND, ...
The Journal of Clinical Endocrinology & Metabolism 65 (5), 994-999, 1987
901987
Atrial natriuretic factor regulates steroidogenic responsiveness and cyclic nucleotide levels in mouse Leydig cells in vitro
KN Pandey, SN Paylou, WJ Kovacs, T Inagami
Biochemical and biophysical research communications 138 (1), 399-404, 1986
891986
Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men
SN PAVLOU, G WAKEFIELD, NL SCHLECHTER, J LINDNER, KH SOUZA, ...
The Journal of Clinical Endocrinology & Metabolism 68 (2), 446-454, 1989
851989
Mice are insensitive to the antitesticular effects of luteinizing hormone-releasing hormone agonists
NG Wang, K Sundaram, S Pavlou, J Rivier, W Vale, CW Bardin
Endocrinology 112 (1), 331-335, 1983
831983
Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis …
D Minaretzis, MM Alper, SP Oskowitz, SM Lobel, JF Mortola, SN Pavlou
American journal of obstetrics and gynecology 172 (5), 1518-1525, 1995
741995
Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men
SN Pavlou, GB Wakefield, DP Island, PG Hoffman, ME Lepage, RL Chan, ...
The Journal of Clinical Endocrinology & Metabolism 64 (5), 931-936, 1987
741987
Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men
SN PAVLOU, RC DEBOLD, DP ISLAND, G WAKEFIELD, J RIVIER, ...
The Journal of Clinical Endocrinology & Metabolism 63 (2), 303-308, 1986
571986
Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist: pharmacodynamic …
JF Mortola, M Sathanandan, S Pavlou, KD Dahl, AJW Hsueh, J Rivier, ...
Fertility and Sterility 51 (6), 957-963, 1989
541989
New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist.
GA McGrath, RJ Goncalves, JK Udupa, RI Grossman, SN Pavlou, ...
The Journal of Clinical Endocrinology & Metabolism 76 (5), 1363-1368, 1993
531993
Hormonal regulation of androgen-binding protein in the rat
BJ DANZO, SN PAVLOU, HL ANTHONY
Endocrinology 127 (6), 2829-2838, 1990
521990
In men with gonadotropin-releasing hormone antagonists
PT Loosen, SE Purdon, SN Pavlou
Am J Psychiatr 151 (2), 271-273, 1994
491994
Gonadotroph adenomas in men produce biologically active follicle-stimulating hormone
AB Galway, AJW HSUEH, L DANESHDOOST, MEIHUA ZHOU, ...
The Journal of Clinical Endocrinology & Metabolism 71 (4), 907-912, 1990
481990
The system can't perform the operation now. Try again later.
Articles 1–20